Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted (PAMVAC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University Hospital Tuebingen
Sponsor:
Collaborators:
University of Copenhagen
Université d'Abomey-Calavi
European Malaria Vaccine Initiative
Institut de Recherche pour le Developpement
Expres2ion Biotechnologies APS
Information provided by (Responsible Party):
University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT02647489
First received: January 4, 2016
Last updated: October 28, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)